Cost-Benefit Analysis of Intravitreal Anti-VEGF Medications for the Treatment of Neovascular Age-Related Macular Degeneration in a Treat-And-Extend Regimen
Volume: 57, Issue: 12, Pages: 4983 - 4983
Published: Sep 26, 2016
Abstract
No abstract.
Paper Details
Title
Cost-Benefit Analysis of Intravitreal Anti-VEGF Medications for the Treatment of Neovascular Age-Related Macular Degeneration in a Treat-And-Extend Regimen
Published Date
Sep 26, 2016
Volume
57
Issue
12
Pages
4983 - 4983
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History